Home > Insider Trading > Filing (0001104659-14-074955)

Filing Details

Accession Number:: 0001104659-14-074955
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-10-29 19:35:54
Reporting Period:: 2014-10-27

Filing Date:: 2014-10-29
Accepted Time:: 2014-10-29 19:35:54
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1359931	Proteon Therapeutics Inc	PRTO	Biological Products, (No Disgnostic Substances) (2836)	000000000

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1277503	Yasunori Kaneko	525 University Avenue, Suite 610 Palo Alto CA 94301	No	No	Yes	No
1296771	Gordon John Freund	525 University Avenue, Suite 610 Palo Alto CA 94301	No	No	Yes	No
1324617	P L Iv Fund Purchaser Qualified Partners Venture Skyline	525 University Avenue, Suite 610 Palo Alto CA 94301	No	No	Yes	No
1392103	Skyline Venture Management Iv, Llc	525 University Avenue, Suite 610 Palo Alto CA 94301	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2014-10-27	200,000	$10.00	200,000	No	4	P	Direct
Common Stock	Acquisiton	2014-10-27	1,167,208	$0.00	1,367,208	No	4	C	Direct
Common Stock	Acquisiton	2014-10-27	121,760	$4.60	1,488,968	No	4	X	Direct
Common Stock	Disposition	2014-10-27	56,038	$10.00	1,432,930	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	C	Direct
No	4	X	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Convertible Preferred Stock	Disposition	2014-10-27	5,000,000	$0.00	375,608	$0.00
Common Stock	Series A-1 Convertible Preferred Stock	Disposition	2014-10-27	2,341,664	$0.00	179,903	$0.00
Common Stock	Series B Convertible Preferred Stock	Disposition	2014-10-27	2,173,913	$0.00	168,680	$0.00
Common Stock	Series C Convertible Preferred Stock	Disposition	2014-10-27	2,436,437	$0.00	189,049	$0.00
Common Stock	Series D Convertible Preferred Stock	Disposition	2014-10-27	3,932,747	$0.00	247,810	$0.00
Common Stock	Warrants (Right to Buy)	Disposition	2014-10-27	121,760	$0.00	121,760	$4.60
Series D Convertible Preferred Stock	Option (Right to Purchase)	Disposition	2014-10-27	1,389,064	$0.00	87,527	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Direct
No	4	C	Direct
No	4	C	Direct
No	4	C	Direct
No	4	C	Direct
No	4	X	Direct
No	4	J	Direct

Footnotes

These shares were purchased in connection with the Issuer's initial public offering of Common Stock.
The shares are held by Skyline Venture Partners Qualified Purchaser Fund IV L.P. ("Skyline"). John G. Freund, M.D. and Yasunori Kaneko, M.D. are Managing Directors of Skyline Venture Management IV, LLC, the sole general partner of Skyline, and may be deemed to share voting and dispositive power over the shares held by Skyline. Each of Drs. Freund and Kaneko disclaim beneficial ownership of such shares, except to the extent of their pecuniary interest therein.
Upon the closing of the Issuer's initial public offering, each share of Series A Convertible Preferred Stock automatically converted into Common Stock on a 1-for-1.19 basis without payment of further consideration and with no expiration date.
Reflects a 1-for-15.87 reverse stock split effected on October 6, 2014.
Upon the closing of the Issuer's initial public offering, each share of Series A-1 Convertible Preferred Stock automatically converted into Common Stock on a 1-for-1.22 basis without payment of further consideration and has no expiration date.
Upon the closing of the Issuer's initial public offering, each share of Series B Convertible Preferred Stock automatically converted into Common Stock on a 1-for-1.23 basis without payment of further consideration and has no expiration date.
Upon the closing of the Issuer's initial public offering, each share of Series C Convertible Preferred Stock automatically converted into Common Stock on a 1-for-1.23 basis without payment of further consideration and has no expiration date.
Upon the closing of the Issuer's initial public offering, each share of Series D Convertible Preferred Stock automatically converted into Common Stock on a one-for-one basis (without payment of further consideration and with no expiration date) plus an additional 6,158 incremental shares as a result of an adjustment as provided for in the Company's certificate of incorporation.
Upon the closing the Issuer's initial public offering, Skyline exercised their warrants to purchase common stock on a net issue basis resulting in the net issuance of 65,722 shares of common stock.
Skyline had a right to purchase shares of Series D Convertible Preferred Stock under the Series D Purchase Agreement at a price of $0.588656, which right to purchase ceased to be exercisable upon the initial filing of the Issuer's registration statement for its initial public offering, and terminated upon the completion of the Issuer's initial public offering of Common Stock. Each share of Series D Preferred Stock issuable upon exercise of the right to purchase would have been convertible into shares of the Issuer's common stock as described in footnote (8) above.